Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Tonix Pharmaceuticals Holding (TNXP) Debt to Equity (2023 - 2024)

Tonix Pharmaceuticals Holding (TNXP) has 2 years of Debt to Equity data on record, last reported at $0.05 in Q4 2024.

  • For Q4 2024, Debt to Equity fell 36.47% year-over-year to $0.05; the TTM value through Dec 2024 reached $0.05, down 36.47%, while the annual FY2024 figure was $0.05, 36.47% down from the prior year.
  • Debt to Equity reached $0.05 in Q4 2024 per TNXP's latest filing, down from $0.11 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.2 in Q2 2024 and bottomed at $0.05 in Q4 2024.